AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇹🇳
PALBOCICLIB in Tunisia
3 products registered with DPM — 0 active, 3 expired
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| IBRANCE Gélule / 100MG | 14943013H | Pfizer Inc USA | expired | 6 Jan 2021 |
| IBRANCE Gélule / 75MG | 14943012H | Pfizer Inc USA | expired | 6 Jan 2021 |
| IBRANCE Gélule / 125MG | 14943011H | Pfizer Inc USA | expired | 6 Jan 2021 |
PALBOCICLIB — DPM Registration Details
DPM (Tunisia) has 3 registered products containing PALBOCICLIB, of which 0 are currently active. Data is sourced directly from the official DPM drug register and refreshed daily.
Track PALBOCICLIB registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.